AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31127720 — intervention group
Group type: EXPERIMENTAL
Intervention: GlycoLeap mobile lifestyle management program
Number of subjects: 100
Study 31127735 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene therapy for Parkinson's
Number of subjects: 0
Study 31127735 — intervention group
Group type: EXPERIMENTAL
Intervention: Accordion Pill
Number of subjects: 0
Study 31127814 — intervention group
Group type: EXPERIMENTAL
Intervention: 1H-NMR analysis of serum samples
Number of subjects: 143
Study 31128146 — intervention group
Group type: EXPERIMENTAL
Intervention: Pencil beam scanning proton beam radiation therapy (PBS-PT) with concurrent 5-fluorouracil (5-FU) and mitomycin C (MMC)
Number of subjects: 25
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 10034
Study 31128285 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic treatment
Number of subjects: 10034
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic exposure
Number of subjects: 10034
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Age 60-69 years
Number of subjects: 10034
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Spring season
Number of subjects: 10034
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Monotherapy
Number of subjects: 10034
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalosporins (monotherapy)
Number of subjects: 10034
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline (monotherapy)
Number of subjects: 10034
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrolide (monotherapy)
Number of subjects: 10034
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (monotherapy)
Number of subjects: 10034
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinolones plus carbapenems (combination therapy)
Number of subjects: 10034
Study 31128285 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinolones (sequential therapy)
Number of subjects: 10034
Study 31128503 — intervention group
Group type: EXPERIMENTAL
Intervention: NOAC (51.4% of patients)
Number of subjects: 24137
Study 31128503 — intervention group
Group type: COMPARATOR
Intervention: VKA (48.6% of patients)
Number of subjects: 24137
Study 31128521 — intervention group
Group type: EXPERIMENTAL
Intervention: RelevarEM registry
Number of subjects: 0
Study 31128598 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-controlled treadmill training
Number of subjects: 13
Study 31129440 — intervention group
Group type: COMPARATOR
Intervention: Current BLS TOR rule
Number of subjects: 4360
Study 31129440 — intervention group
Group type: EXPERIMENTAL
Intervention: New KoCARC TOR rules (combination of asystole and age > 60 years with current TOR rule)
Number of subjects: 4360
Study 31129514 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated with bi- or quadrivalent HPV vaccine
Number of subjects: 55
Study 31129514 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated
Number of subjects: 55
Study 31129514 — intervention group
Group type: EXPERIMENTAL
Intervention: First-void urine
Number of subjects: 55
Study 31129576 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus groups with clinicians during the preintervention period
Number of subjects: 8
Study 31129576 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of pain-agitation-delirium guidelines
Number of subjects: 8
Study 31129576 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of challenges in sedation management
Number of subjects: 8
Study 31129582 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for breast cancer
Number of subjects: 0
Study 31129582 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for gastric cancer
Number of subjects: 0
Study 31129582 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for colorectal cancer
Number of subjects: 0
Study 31130229 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in ACPA levels (>10%)
Number of subjects: 840
Study 31130229 — intervention group
Group type: COMPARATOR
Intervention: No change in ACPA levels (-10% to +10%)
Number of subjects: 840
Study 31130229 — intervention group
Group type: COMPARATOR
Intervention: Increase in ACPA levels (>+10%)
Number of subjects: 840
Study 31130500 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroidectomy
Number of subjects: 43
Study 31131388 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortic valve replacement (AVR)
Number of subjects: 34
Study 31131388 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical AVR
Number of subjects: 34
Study 31131388 — intervention group
Group type: EXPERIMENTAL
Intervention: Model-based therapy planning
Number of subjects: 34
Study 31131388 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 34
Study 31131846 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot Medroxyprogesterone Acetate (DMPA)
Number of subjects: 50
Study 31131846 — intervention group
Group type: COMPARATOR
Intervention: Nonhormonal contraception
Number of subjects: 50
Study 31132092 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-processed food intake (measured as percentage of total energy intake)
Number of subjects: 1822
Study 31132092 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of specific ultra-processed food groups (yogurts and fermented milks, cakes and pastries, nonalcoholic beverages)
Number of subjects: 1822
Study 31132118 — intervention group
Group type: EXPERIMENTAL
Intervention: Kisspeptin administration
Number of subjects: 0
Study 31132118 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid antagonism (naloxone)
Number of subjects: 0
Study 31132118 — intervention group
Group type: COMPARATOR
Intervention: NKB and dynorphin signaling
Number of subjects: 0
Study 31133076 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop system (innovative health technology for blood glucose regulation)
Number of subjects: 24
Study 31133575 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic bioimpedance (TB) and inert gas rebreathing (IGR) techniques
Number of subjects: 0
Study 31133575 — intervention group
Group type: COMPARATOR
Intervention: Doppler echocardiography
Number of subjects: 0
Study 31133596 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pregnanediol glucuronide (PDG) urine test
Number of subjects: 25
Study 31133597 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour blood pressure measurement (1-BPM)
Number of subjects: 214
Study 31133597 — intervention group
Group type: COMPARATOR
Intervention: Office blood pressure monitoring (OBPM)
Number of subjects: 214
Study 31133597 — intervention group
Group type: COMPARATOR
Intervention: Home blood pressure monitoring (HBPM)
Number of subjects: 214
Study 31133597 — intervention group
Group type: COMPARATOR
Intervention: 24-hour ambulatory blood pressure monitoring (ABPM)
Number of subjects: 214
Study 31133863 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent exercise regimen (resistance exercise + functional exercise)
Number of subjects: 46
Study 31133863 — intervention group
Group type: COMPARATOR
Intervention: Leucine-enriched whey protein isolate supplementation
Number of subjects: 46
Study 31133889 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency neuronavigated repetitive transcranial magnetic stimulation (10 Hz)
Number of subjects: 0
Study 31133889 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 0
Study 31133899 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention for depression, details on dosage and duration not available
Number of subjects: 0
Study 31133899 — intervention group
Group type: COMPARATOR
Intervention: Control group, details not available
Number of subjects: 0
Study 31133946 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Intervention (MBI)
Number of subjects: 71
Study 31133946 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 71
Study 31133957 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Bitartrate
Number of subjects: 0
Study 31134171 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 0.2% Eye Micro-Drops
Number of subjects: 0
Study 31134474 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized fluid challenge during cardiac surgery
Number of subjects: 0
Study 31134474 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 31135462 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (15-minute traditional needle acupuncture sessions)
Number of subjects: 42
Study 31135462 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 42
Study 31135970 — intervention group
Group type: EXPERIMENTAL
Intervention: ATIR101 (photodepletion strategy)
Number of subjects: 19
Study 31136561 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Enterography (MRE)
Number of subjects: 237
Study 31136561 — intervention group
Group type: EXPERIMENTAL
Intervention: MRE-VAS for Mucosal Healing (MH)
Number of subjects: 237
Study 31136561 — intervention group
Group type: EXPERIMENTAL
Intervention: MaRIA score
Number of subjects: 237
Study 31136561 — intervention group
Group type: EXPERIMENTAL
Intervention: Imputed ileal SES-CD
Number of subjects: 237
Study 31136607 — intervention group
Group type: EXPERIMENTAL
Intervention: Radium-223
Number of subjects: 20
Study 31136632 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Health Questionnaire (PHQ-9)
Number of subjects: 1004
Study 31136632 — intervention group
Group type: EXPERIMENTAL
Intervention: Beck-Depression Inventory II (BDI-II)
Number of subjects: 1004
Study 31136632 — intervention group
Group type: COMPARATOR
Intervention: Anti-depressive therapy
Number of subjects: 1004
Study 31136925 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin AUC-10 (3 cycles)
Number of subjects: 48
Study 31136925 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin AUC-10 (4 cycles)
Number of subjects: 48
Study 31136925 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin AUC-10
Number of subjects: 48
Study 31138229 — intervention group
Group type: EXPERIMENTAL
Intervention: PD-1 blockade (pembrolizumab) combined with radiation (3 × 8 Gy) and immune/environmental-targeting compounds (vitamin D, lansoprazole, aspirin, cyclophosphamide, curcumin)
Number of subjects: 49
Study 31138381 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper airway surgery
Number of subjects: 30
Study 31138499 — intervention group
Group type: EXPERIMENTAL
Intervention: Good fitness
Number of subjects: 469
Study 31138499 — intervention group
Group type: COMPARATOR
Intervention: Overweight
Number of subjects: 469
Study 31138588 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrotinib 160 mg, 240 mg, 320 mg, or 400 mg once daily plus capecitabine 1,000 mg/m²
Number of subjects: 28
Study 31138588 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrotinib in combination with capecitabine
Number of subjects: 28
Study 31138673 — intervention group
Group type: EXPERIMENTAL
Intervention: AXOS-enriched diet
Number of subjects: 0
Study 31138805 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta-24-RGD
Number of subjects: 0
Study 31139138 — intervention group
Group type: EXPERIMENTAL
Intervention: Bruxism Episode Index in patients with significant headache impact (HIT-6 score ≥ 50)
Number of subjects: 0
Study 31139138 — intervention group
Group type: EXPERIMENTAL
Intervention: Bruxism associated with arousal
Number of subjects: 0
Study 31139146 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF treatment following POSEIDON criteria
Number of subjects: 4828
Study 31139420 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized strength training program based on MEP amplitude (low: 35-50% 1RM, moderate: 50-65% 1RM, high: 70-80% 1RM) combined with anodal tDCS.
Number of subjects: 84
Study 31139420 — intervention group
Group type: COMPARATOR
Intervention: Individualized strength training program based on MEP amplitude (low, moderate, high) combined with sham tDCS.
Number of subjects: 84
Study 31139423 — intervention group
Group type: EXPERIMENTAL
Intervention: Transnasal gastroscopy (nEGD)
Number of subjects: 196
Study 31139423 — intervention group
Group type: COMPARATOR
Intervention: Peroral gastroscopy (oEGD)
Number of subjects: 196
Study 31139431 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-CBT intervention (8 weekly group sessions)
Number of subjects: 7
Study 31139441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-use supplementary foods (RUSF; PlumpySup)
Number of subjects: 0
Study 31139441 — intervention group
Group type: EXPERIMENTAL
Intervention: Specially formulated corn-soy blend (CSB++; Super Cereal Plus)
Number of subjects: 0
Study 31139441 — intervention group
Group type: EXPERIMENTAL
Intervention: Misola (micronutrient-fortified cereal-legume blend)
Number of subjects: 0
Study 31139441 — intervention group
Group type: EXPERIMENTAL
Intervention: Locally milled flour (LMF)
Number of subjects: 0
Study 31139441 — intervention group
Group type: COMPARATOR
Intervention: No MAM treatment
Number of subjects: 0
Study 31139442 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated call and text immunisation reminders
Number of subjects: 300
Study 31139442 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 300
Study 31139640 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh pomegranate juice (PJ) at 1.5 mL per kg body weight
Number of subjects: 59
Study 31139640 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 59
Study 31139766 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg folic acid/d (higher strength)
Number of subjects: 345
Study 31139766 — intervention group
Group type: COMPARATOR
Intervention: 0.8 mg folic acid/d (standard of care)
Number of subjects: 345
Study 31139996 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic bilateral groin hernia repair with one large self-fixating mesh
Number of subjects: 100
Study 31140003 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 601
Study 31140003 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 601
Study 31140003 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (younger than 70)
Number of subjects: 601
Study 31140003 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (older subgroup)
Number of subjects: 601
Study 31140003 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (advanced stages)
Number of subjects: 601
Study 31140199 — intervention group
Group type: EXPERIMENTAL
Intervention: School staff measurements of height and weight
Number of subjects: 1008
Study 31140199 — intervention group
Group type: COMPARATOR
Intervention: Researcher measurements of height and weight
Number of subjects: 1008
Study 31140667 — intervention group
Group type: EXPERIMENTAL
Intervention: Labels used to describe themselves and when speaking with others who use drugs, with family and with treatment providers
Number of subjects: 263
Study 31140667 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred labels for others to call them
Number of subjects: 263
Study 31140667 — intervention group
Group type: EXPERIMENTAL
Intervention: Labels participants never wanted to be called
Number of subjects: 263
Study 31140667 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of slang terms
Number of subjects: 263
Study 31141105 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score based on 3 common Lp(a)-raising variants
Number of subjects: 1009
Study 31141105 — intervention group
Group type: EXPERIMENTAL
Intervention: High Lp(a) levels (≥60 mg/dL) in first-degree relatives of patients with CAVS
Number of subjects: 1009
Study 31141592 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolate spheroidal coordinate system for mapping cardiac imaging data
Number of subjects: 0
Study 31141631 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib and Venetoclax
Number of subjects: 80
Study 31141830 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR-integrated patient portal
Number of subjects: 55
Study 31141830 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-intervention)
Number of subjects: 55
Study 31142037 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line triplet or doublet chemotherapy combined with targeted therapy
Number of subjects: 0
Study 31142305 — intervention group
Group type: EXPERIMENTAL
Intervention: Food-insecure students
Number of subjects: 855
Study 31142305 — intervention group
Group type: COMPARATOR
Intervention: Students with on-campus pantry awareness
Number of subjects: 855
Study 31142305 — intervention group
Group type: COMPARATOR
Intervention: Food-insecure students utilizing the pantry
Number of subjects: 855
Study 31142314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen use at rest
Number of subjects: 662
Study 31142314 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower forced vital capacity (FVC) % predicted
Number of subjects: 662
Study 31142314 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower diffusion capacity for carbon monoxide (DLco) % predicted
Number of subjects: 662
Study 31142314 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥62 years
Number of subjects: 662
Study 31142314 — intervention group
Group type: EXPERIMENTAL
Intervention: Age <62 years
Number of subjects: 662
Study 31142357 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary chemotherapy
Number of subjects: 41
Study 31142450 — intervention group
Group type: EXPERIMENTAL
Intervention: High consumption of ultra-processed foods (highest quarter)
Number of subjects: 19899
Study 31142450 — intervention group
Group type: EXPERIMENTAL
Intervention: Each additional serving of ultra-processed foods
Number of subjects: 19899
Study 31142450 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher consumption of ultra-processed foods (>4 servings daily)
Number of subjects: 19899
Study 31142457 — intervention group
Group type: EXPERIMENTAL
Intervention: High consumption of ultra-processed foods (fourth quarter)
Number of subjects: 105159
Study 31142457 — intervention group
Group type: COMPARATOR
Intervention: Low consumption of ultra-processed foods (first quarter)
Number of subjects: 105159
Study 31142503 — intervention group
Group type: EXPERIMENTAL
Intervention: CIV rhIL15 at 2 μg/kg/day
Number of subjects: 27
Study 31142503 — intervention group
Group type: EXPERIMENTAL
Intervention: CIV rhIL15 at various doses (0.125, 0.25, 0.5, 1, 2, or 4 μg/kg/day)
Number of subjects: 27
Study 31142507 — intervention group
Group type: EXPERIMENTAL
Intervention: Voxel Forecast multiscale regression framework for predicting tumor voxel standardized uptake value (SUV) on PETmid from baseline patient-level and voxel-level covariates.
Number of subjects: 25
Study 31142507 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined patient- and voxel-level forecasts using Voxel Forecast.
Number of subjects: 25
Study 31142518 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee pain group
Number of subjects: 504
Study 31142518 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 504
Study 31142594 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG criteria for AMI diagnosis
Number of subjects: 8830
Study 31142594 — intervention group
Group type: EXPERIMENTAL
Intervention: hs-cTnT and hs-cTnI concentrations at presentation
Number of subjects: 8830
Study 31142594 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic algorithm combining ECG criteria with hs-cTnT/I concentrations
Number of subjects: 8830
Study 31143111 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-ingredient nutritional supplementation with exercise training
Number of subjects: 49
Study 31143111 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-ingredient nutritional supplementation without exercise training
Number of subjects: 49
Study 31143111 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 49
Study 31143160 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy Protein with Isoflavones
Number of subjects: 0
Study 31143160 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy Protein without Isoflavones
Number of subjects: 0
Study 31143160 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa with Isoflavones
Number of subjects: 0
Study 31143160 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa without Isoflavones
Number of subjects: 0
Study 31143160 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31143849 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorghum-based fortified blended foods (FBFs)
Number of subjects: 0
Study 31143849 — intervention group
Group type: EXPERIMENTAL
Intervention: Cowpea-based fortified blended foods (FBFs)
Number of subjects: 0
Study 31143849 — intervention group
Group type: EXPERIMENTAL
Intervention: Extruded corn-soy blend 14
Number of subjects: 0
Study 31143849 — intervention group
Group type: COMPARATOR
Intervention: Corn-soy blend plus (CSB+)
Number of subjects: 0
Study 31143849 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 0
Study 31143877 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 921
Study 31143877 — intervention group
Group type: COMPARATOR
Intervention: Inflammation-exposed anhaptoglobinemic or hypohaptoglobinemic (Category 3)
Number of subjects: 921
Study 31143877 — intervention group
Group type: EXPERIMENTAL
Intervention: Hp1-2 or Hp2-2 phenotypes
Number of subjects: 921
Study 31143880 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabectedin (T) at dose level 1 (1.5 mg/m2) in combination with radiation therapy (RT) (45 Gy in 25 fractions of 1.8 Gy each)
Number of subjects: 14
Study 31144666 — intervention group
Group type: EXPERIMENTAL
Intervention: AA plus smartphone app (n=19)
Number of subjects: 59
Study 31144666 — intervention group
Group type: EXPERIMENTAL
Intervention: AA alone (n=19)
Number of subjects: 59
Study 31144666 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (n=21)
Number of subjects: 59
Study 31144670 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep education plus PHM device (Shine 2, Misfit)
Number of subjects: 100
Study 31144670 — intervention group
Group type: COMPARATOR
Intervention: Sleep education alone
Number of subjects: 100
Study 31145415 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of PF-06801591 at escalating doses (0.5, 1, 3, or 10 mg/kg) every 3 weeks
Number of subjects: 40
Study 31145415 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous administration of PF-06801591 at a single dose level of 300 mg every 4 weeks
Number of subjects: 40